Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection

NCT02206789 is registered in ClinicalTrials.gov with Aravind Eye Care System as lead sponsor.

NCT NCT02206789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02206789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection
Lead sponsor
Aravind Eye Care System
Phase
Not applicable
Overall status
Unknown status
Start date
February 29, 2012
Completion date
December 31, 2017
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal graft rejection